Related Experiment Video
Updated: Oct 29, 2025

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
Published on: July 6, 2021
Constructing Smartphone-Controlled Optogenetic Switches in Mammalian Cells.
Yuanhuan Yu1, Guiling Yu1, Haifeng Ye2
1Synthetic Biology and Biomedical Engineering Laboratory, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
Researchers developed smartphone-controlled optogenetic switches for remote control of transgene expression. This innovation enables precise regulation of therapeutic protein production using far-red light, advancing mobile health monitoring.
Area of Science:
- Biotechnology
- Mobile Health Technology
- Optogenetics
Background:
- Smartphones are integral to daily life, facilitating mobile health (mHealth) applications.
- Remote health monitoring is enhanced by integrated sensors and communication technologies.
Purpose of the Study:
- To construct smartphone-controlled optogenetic switches for ultra-remote transgene expression.
- To enable precise regulation of therapeutic outputs using optically engineered cells.
Main Methods:
- Utilized a multidisciplinary approach combining smart electronics, software, and optogenetics.
- Designed a custom SmartController system to process smartphone signals and control a far-red light-emitting diode (LED) module.
- Developed an optogenetic interface responsive to far-red light (FRL) for transgene expression control.
Main Results:
- Successfully constructed smartphone-controlled optogenetic switches.
- Demonstrated regulation of therapeutic outputs via an FRL-responsive optogenetic interface.
- Detailed protocols for circuit design, cell culture, transfection, LED module implementation, and reporter assays were established.
Conclusions:
- Smartphone-controlled optogenetic switches offer a novel platform for remote control of gene expression.
- This technology holds potential for advanced mHealth applications and targeted therapeutic production.
- The developed system provides a robust framework for FRL-triggered transgene expression.

